Human Serum Dilution
Human Serum Dilution - Related Videos
06:44
Isolation of Small Noncoding RNAs from Human Serum
0 Views •
Cited by 13 •
2014
This protocol describes a method for extracting small RNAs from human serum. We have used this method to isolate microRNAs from cancer serum for use in DNA arrays and also singleplex quantitative PCR. The protocol utilizes phenol and guanidinium thiocyanate reagents with modifications to yield high quality RNA.
05:33
A Microneutralization Assay to Measure Neutralizing Antibody Titers in Human Serum
0 Views •
2025
This video demonstrates Microneutralization assays to measure neutralizing antibodies using Madin-Darby Canine Kidney cells overexpressing α2,6-linked sialic acid in human sera. This assay is often used for influenza human...
03:52
An Assay to Detect Autoantibodies in Human Serum using a Hippocampal Neuronal Culture
0 Views •
2025
This video demonstrates a technique for identifying antibodies against specific antigens in a sample using a rat hippocampal neuronal culture. By exposing cultured neurons to patient samples containing autoantibodies targeting N-Methyl-D-aspartate receptors (NMDARs), the presence of autoantibodies bound to the neuronal surface is revealed through immunostaining.
02:59
Solution Concentration and Dilution
0 Views •
2020
The relative amount of a given solution component is known as its concentration. Often, though not always, a solution contains one component with a concentration that is significantly greater than that of all other components. This component is called the solvent and may be viewed as the medium in which the other components are dispersed or dissolved. Solutions in which water is the solvent are, of course, very common on our planet. A solution in which water is the solvent is called an aqueous...
02:55
Determining the Role of Vitronectin in Bacterial Resistance to Bactericidal Activity of Human Serum
0 Views •
2025
This video demonstrates the role of vitronectin, a human serum glycoprotein, on bacterial resistance. Antibodies in the serum interact with bacterial surface proteins, activating complement proteins and forming the membrane attack complex, causing bacterial cell lysis. Vitronectin binding on bacterial membrane protein prevents the membrane attack complex formation, resulting in bacterial survival.
FAQs
Each dilution represents a known reduction in serum concentration, so the endpoint can be reported as the highest dilution that still produces the defined assay response. A response that persists across more dilution steps indicates greater relative immune reactivity under the assay conditions. Interpretation therefore depends on the selected endpoint and consistent testing across samples.
Dilution can reduce matrix effects caused by concentrated serum components and bring an assay signal into its measurable range. This helps the response reflect interactions with the standardized antigen, pathogen-derived material, or reagent rather than excessive background or signal saturation. The approach is especially useful when undiluted serum produces an unclear or difficult-to-compare result.
A serial dilution creates a range of serum concentrations that reveals how the measured response changes as antibodies, complement proteins, and other components decrease. Testing this range supports endpoint determination and comparison between samples. It also reduces reliance on one potentially uninformative concentration, particularly when immune reactivity differs substantially among specimens.
Twofold and tenfold series apply different step sizes between successive serum preparations. A twofold series provides more closely spaced concentrations, whereas a tenfold series covers concentration changes more rapidly. The choice affects how precisely the response endpoint can be localized and how broadly the tested range spans, while both require defined dilution volumes and consistent assay conditions.
A typical workflow establishes the serum, a defined diluent volume, and the intended dilution series before testing. Serum is mixed with diluent in successive twofold or tenfold steps, and each preparation is then exposed to the same standardized antigen, pathogen-derived material, or assay reagent. Responses are compared across the series to identify the defined endpoint.
The tested material and the response criterion should remain consistent across the dilution series. Depending on the experiment, this may involve a standardized antigen, pathogen-derived material, or assay reagent, together with a defined endpoint for interpreting the signal. Consistency allows differences across dilution steps or serum samples to be attributed more meaningfully to serum concentration.
The method supports several infection-related investigations, including serology, neutralization studies, complement-dependent assays, and comparisons of immune responses between samples. By examining responses across controlled serum concentrations, researchers can estimate antibody titers or relative reactivity and assess how serum activity changes under the conditions of a particular immunological test.
Comparisons are based on the dilution level at which each sample reaches the same defined response criterion, or on the relative responses observed across equivalent dilution steps. A sample that remains reactive at a greater dilution may show stronger relative immune reactivity in that assay. Such comparisons require the same testing materials, dilution scheme, and interpretation threshold.